Ohcanbohtosat - Irlbeck, David

Selection of High-Level Resistance to Human Immunodeficiency Virus Type 1 Protease Inhibitors Dahkki Watkins, Terri, Resch, Wolfgang, Irlbeck, David, Swanstrom, Ronald

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Virologic Failure in First-Line Human Immunodeficiency Virus Therapy with a CCR5 Entry Inhibitor, Aplaviroc, plus a Fixed-Dose Combination of Lamivudine-Zidovudine: Nucleoside Reve... Dahkki Demarest, James F., Amrine-Madsen, Heather, Irlbeck, David M., Kitrinos, Kathryn M.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Virologic Failure in Therapy-Naïve Subjects on Aplaviroc plus Lopinavir-Ritonavir: Detection of Aplaviroc Resistance Requires Clonal Analysis of Envelope Dahkki Kitrinos, Kathryn M., Amrine-Madsen, Heather, Irlbeck, David M., Word, J. Michael, Demarest, James F.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Efficacy and Safety of Abacavir/Lamivudine/Zidovudine Plus Tenofovir in HBV/HIV-1 Coinfected Adults: 48-Week Data Dahkki Rodriguez, Allan E, DeJesus, Edwin, Williams, Vanessa, Irlbeck, David, Ross, Lisa, Ha, Belinda, Lancaster, Charles T

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Interplay between Single Resistance-Associated Mutations in the HIV-1 Protease and Viral Infectivity, Protease Activity, and Inhibitor Sensitivity Dahkki Henderson, Gavin J., Lee, Sook-Kyung, Irlbeck, David M., Harris, Janera, Kline, Melissa, Pollom, Elizabeth, Parkin, Neil, Swanstrom, Ronald

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Minority HIV-1 Drug Resistance Mutations Are Present in Antiretroviral Treatment–Naïve Populations and Associate with Reduced Treatment Efficacy Dahkki Johnson, Jeffrey A, Li, Jin-Fen, Wei, Xierong, Lipscomb, Jonathan, Irlbeck, David, Craig, Charles, Smith, Amanda, Bennett, Diane E, Monsour, Michael, Sandstrom, Paul, Lanier, E. Randall, Heneine, Walid

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, m... Dahkki Irlbeck, David M, Vernon, Suzanne D, McCleary, K Kimberly, Bateman, Lucinda, Klimas, Nancy G, Lapp, Charles W, Peterson, Daniel L, Brown, James R, Remlinger, Katja S, Wilfret, David A, Gerondelis, Peter

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Vaccination of Macaques against Pathogenic Simian Immunodeficiency Virus with Venezuelan Equine Encephalitis Virus Replicon Particles Dahkki Davis, Nancy L., Caley, Ian J., Brown, Kevin W., Betts, Michael R., Irlbeck, David M., McGrath, Kathryn M., Connell, Mary J., Montefiori, David C., Frelinger, Jeffrey A., Swanstrom, Ronald, Johnson, Philip R., Johnston, Robert E.

Viečča ollesdeavstta Viečča ollesdeavstta

Vaccination of Macaques against Pathogenic Simian Immunodeficiency Virus with Venezuelan Equine Encephalitis Virus Replicon Particles Dahkki Davis, Nancy L., Caley, Ian J., Brown, Kevin W., Betts, Michael R., Irlbeck, David M., McGrath, Kathryn M., Connell, Mary J., Montefiori, David C., Frelinger, Jeffrey A., Swanstrom, Ronald, Johnson, Philip R., Johnston, Robert E.

Viečča ollesdeavstta

Th17 cell master transcription factor RORC2 regulates HIV-1 gene expression and viral outgrowth Dahkki Wiche Salinas, Tomas Raul, Zhang, Yuwei, Sarnello, Daniele, Zhyvoloup, Alexander, Marchand, Laurence Raymond, Fert, Augustine, Planas, Delphine, Lodha, Manivel, Chatterjee, Debashree, Karwacz, Katarzyna, Oxenford, Sally, Routy, Jean-Pierre, Irlbeck, David, Amrine-Madsen, Heather, Ancuta, Petronela, Fassati, Ariberto

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Synthesis and Biological Evaluation of Macrocyclized Betulin Derivatives as a Novel Class of Anti-HIV-1 Maturation Inhibitors Dahkki Tang, Jun, Jones, Stacey A., Jeffery, Jerry L., Miranda, Sonia R., Galardi, Cristin M., Irlbeck, David M., Brown, Kevin W., McDanal, Charlene B., Han, Nianhe, Gao, Daxin, Wu, Yongyong, Shen, Bin, Liu, Chunyu, Xi, Caiming, Yang, Heping, Li, Rui, Yu, Yajun, Sun, Yufei, Jin, Zhimin, Wang, Erjuan, Johns, Brian A.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Combined noncanonical NF-κB agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivo Dahkki Falcinelli, Shane D., Peterson, Jackson J., Turner, Anne-Marie W., Irlbeck, David, Read, Jenna, Raines, Samuel L.M., James, Katherine S., Sutton, Cameron, Sanchez, Anthony, Emery, Ann, Sampey, Gavin, Ferris, Robert, Allard, Brigitte, Ghofrani, Simon, Kirchherr, Jennifer L., Baker, Caroline, Kuruc, JoAnn D., Gay, Cynthia L., James, Lindsey I., Wu, Guoxin, Zuck, Paul, Rioja, Inmaculada, Furze, Rebecca C., Prinjha, Rab K., Howell, Bonnie J., Swanstrom, Ronald, Browne, Edward P., Strahl, Brian D., Dunham, Richard M., Archin, Nancie M., Margolis, David M.

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo Dahkki Nixon, Christopher C., Mavigner, Maud, Sampey, Gavin C., Brooks, Alyssa D., Spagnuolo, Rae Ann, Irlbeck, David M., Mattingly, Cameron, Ho, Phong T., Schoof, Nils, Cammon, Corinne G., Tharp, Greg K., Kanke, Matthew, Wang, Zhang, Cleary, Rachel A., Upadhyay, Amit A., De, Chandrav, Wills, Saintedym R., Falcinelli, Shane D., Galardi, Cristin, Walum, Hasse, Schramm, Nathaniel J., Deutsch, Jennifer, Lifson, Jeffrey D., Fennessey, Christine M., Keele, Brandon F., Jean, Sherrie, Maguire, Sean, Liao, Baolin, Browne, Edward P., Ferris, Robert G., Brehm, Jessica H., Favre, David, Vanderford, Thomas H., Bosinger, Steven E., Jones, Corbin D., Routy, Jean-Pierre, Archin, Nancie M., Margolis, David M., Wahl, Angela, Dunham, Richard M., Silvestri, Guido, Chahroudi, Ann, Garcia, J. Victor

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta